In pediatric patients, “group 3” non-WNT/non-SHH medulloblastomas contain standard-risk medulloblastomas (not behaving differently from “group 4” patients) as well as MYC-amplified tumors showing mostly a very poor prognosis. Here, MYC is linked to medulloblastoma.